基本分析
透過季節調整季營收，判斷美股整體趨勢，但注意股價有時候領先基本面的數據，應搭配其他領先指標判斷。
基本資料
個股的基本資料，以及所屬的類股和產業。
公司介紹
業務介紹
吉利德科學公司是一家生物製藥公司，致力於在美國、歐洲和國際市場上開發、生產和銷售未滿足醫療需求的藥物。該公司提供Biktarvy、Genvoya、Descovy、Odefsey、Truvada、Complera/Eviplera、Stribild和Atripla等產品，用於治療HIV/AIDS；Veklury是一種用於靜脈注射治療2019冠狀病毒病的藥物；Epclusa、Harvoni、Vosevi、Vemlidy和Viread則用於治療肝病。此外，該公司還提供Yescarta、Tecartus、Trodelvy和Zydelig等產品，用於治療血液學、腫瘤學和細胞治療患者。此外，該公司還提供Letairis口服制劑，用於治療肺動脈高壓；Ranexa口服制劑，用於治療慢性心絞痛；以及AmBisome脂質體制劑，用於治療嚴重侵襲性真菌感染。吉利德科學公司與Arcus Biosciences, Inc.、Pionyr Immunotherapeutics Inc.、Tizona Therapeutics, Inc.、Tango Therapeutics, Inc.、Jounce Therapeutics, Inc.、Galapagos NV、Janssen Sciences Ireland Unlimited Company、Japan Tobacco, Inc.、Gadeta B.V.、Bristol-Myers Squibb Company、Dragonfly Therapeutics, Inc.和Merck & Co, Inc.等公司簽訂了合作協議。該公司成立於1987年，總部位於加利福尼亞州福斯特城。
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
警語
1. 資料僅供參考，不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整，需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。
